Replies to post #539398 on NorthWest Biotherapeutics Inc (NWBO)

[Kaizenman]

PM: Yes, I did not think that through to realize that multiple JVs on the same IP is frought with potential legal issus. Thanks!

Peace.

[vator]

It is not the first time you have brought this structure up. I would be happy with it but I will believe it when I see it. The same with any deal. I hope this BOD finally bucks up and makes some magic happen. So far they have been MIA.

[Bright Boy]

Great comment from a very experienced "deal" guy!!!

Cheers,

BB

[dennisdave]

PM I hate to say but I think you will have to put the idea of a BO of NWBO or even a JV into the freezer for at least another year or so. Im pretty sure that's not where they are right now alas.

I fear they will want all approvals first before being bought :(

[jimmy667]

It is possible to have a JV company with multiple BPs. Along the lines of this:

https://www.pfizer.com/news/press-release/press-release-detail/pfizer_announces_closing_of_joint_venture_with_glaxosmithkline_to_create_a_premier_global_consumer_healthcare_company

Another example is Merus NV. After it's IPO in May 2016 it traded in $7 handle. A few months later in August-September 2017 it rose rapidly to $30 plus over next six months when it became widely known that the MRUS stock was more than 70% owned by Pfizer and other BPs. So Merus NV is a JV including several BPs in the area of Immune-oncology.
Merus NV stated description of their business:
"Merus NV is the Netherlands - based biotechnology company, concentrated on developing differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Multiclonics format. Its products are designed to bind to multiple targets, and are manufactured with features for anti-cancer effects against the complex mechanisms that drive cancer. Company's products engage cancer antigens and harness the power of the immune system to kill tumor cells by utilizing technology platform. One of the drug zenocutuzumab (Zeno), a Biclonics antibody, concentrates on helping patients with lung, pancreatic and other types of solid tumors. The company operates in the Netherlands and United States."

Imagine what would happen if NWBO, Merck and BMY join in a new venture to start a new company with Merck & BMY (or just one of them) capitalizing the new the new company with Cash and providing expertise and NWBO exchanges all of its stock and IP for shares in the New Company to to IPO on Nasdaq. Now imagine what would happen to any Hedge Funds that hold NWBO stock short? Imagine if the short shares were in the 100s of millions? Forced cover. If I was Linda Powers this is what I would do if there were BPs wanting to partner. Linda Powers is smarter than me and clearly by the "considering litigation" statement has an AXE to grind with the short selling "Wolf Pack"

[Kap10jak]

If DCVAX-L is to be SOC like everyone is saying what would be the advantage of a partnership? Wouldn't all BPs have the right to use DCVAX-L along with their drugs anyway as long as they paid full price for it? Maybe the patent regarding combinations?

[dstock07734]

PM, great analysis! Thanks always.

[Horseb4CarT]

Shouldn’t be too much of an issue if multiple licensing deals, and they all use murcidencel in their combo treatments so everyones successful combo equals murcidencel revenue plus licensing fees.

[Doc logic]

Poor Man -,

From a business perspective that seems to be a good way to look at this. I believe NWBO still wants to protect L/Direct combo research for certain potential situations where properly activated but reduced pace or more complete immune response is more desirable as synergy was noted in early DC research between intradermal and intratumoral injections by Triozzi et al. This may be taken care of by other combos but safety would likely not be an issue with this one. This synergy seems to point to a more complete local and systemic response. I expect their thinking about this to be clarified before being handed over Carte Blanche as progress with L is made. Best wishes.

[Doc logic]

PoorMan-,

You may want to ask Ms Katherine Wolf EX Ondra partner. You may also want to ask an EX CEO of Cenkos who left suddenly in 2017 after Dr. Navid Malik was forced out of his consultant position there and the Woodford saga. You may also want to ask any potential suitors if they have been very well vetted and made aware of NWBO’s position of strength with regard to IP protection you may even want to ask Wes Christian if Mr. Black has been helpful to them with evidence that might be used to build a case against some of the manipulators. My guess is there is a story in there somewhere. Best wishes.